| Literature DB >> 28747866 |
Ting Shen1, Gongcheng Wang2, Long You1, Liang Zhang1, Haiwei Ren3, Weicheng Hu1, Qian Qiang1, Xinfeng Wang1, Lilian Ji1, Zhengzhong Gu1,4, Xiangxiang Zhao1.
Abstract
Wheat bran-derived polysaccharides have attracted particular attention due to their immunomodulatory effects. However, the molecular mechanisms underlying their functions are poorly understood. The current study was designed to examine the effect of wheat bran polysaccharide (WBP) on RAW 264.7 cells and the underlying signaling pathways, which have not been explored. In addition, we also investigated the immuno-enhancement effects of WBP on cyclophosphamide (CTX)-induced immunosuppression in mice. WBP significantly increased the concentrations of intracellular nitric oxide (NO) and cytokines such as prostaglandin E2 (PGE2) and tumor necrosis factor-α (TNF-α) in RAW 264.7 cells. The result of RT-PCR analysis indicated that WBP also enhanced inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and TNF-α expression. Further analyses demonstrated that WBP rapidly activated phosphorylated p38 mitogen-activated protein kinase (MAPK) and the transcriptional activities of activator protein-1 (AP-1) and nuclear factor (NF)-κB via toll-like receptor 4 (TLR4). Furthermore, in vivo experiments revealed that WBP increased the spleen and thymus indices significantly, and markedly promoted the production of the serum cytokines IL-2 and IFN-γ in CTX-induced immunosuppressed mice. Taken together, these results suggest that WBP can improve immunity by enhancing immune function, and could be explored as a potential immunomodulatory agent in functional food.Entities:
Keywords: RAW 264.7 macrophages; Wheat bran polysaccharide; immunomodulatory activity; toll-like receptor 4
Year: 2017 PMID: 28747866 PMCID: PMC5510218 DOI: 10.1080/16546628.2017.1344523
Source DB: PubMed Journal: Food Nutr Res ISSN: 1654-661X Impact factor: 3.894
Primer sequences and conditions for RT-PCR.
| Target genes | Primer sequence (5ʹ-3ʹ) | Annealing Tm (°C) | PCR cycles |
|---|---|---|---|
| GAPDH | F: CACTCACGGCAAATTCAACGGCA | 60 | 30 |
| R: GACTCCACGACATACTCAGCAC | |||
| iNOS | F: CCCTTCCGAAGTTTCTGGCAGCAG | 60 | 27 |
| R: GGCTGTCAGAGCCTCGTGGCTTTGG | |||
| COX-2 | F: CACTACATCCTGACCCACTT | 55 | 30 |
| R: ATGCTCCTGCTTGAGTATGT | |||
| TNF-α | F: TGCCTATGTCTCAGCCTCTTC | 55 | 30 |
| R: GAGGCCATTTGGGAACTTCT |
Group classification of C57BL/6 mice.
| Group | Treatment |
|---|---|
| Normal | Control mice +vehicle treatment |
| CTX | CTX 30 mg kg–1 (i.p.) |
| CTX + low dose WBP | CTX 30 mg kg–1 (i.p.)+ 50 mg kg–1 WBP (i.g.) |
| CTX + medium dose WBP | CTX 30 mg kg–1 (i.p.)+ 100 mg kg–1 WBP (i.g.) |
| CTX + high dose WBP | CTX 30 mg kg–1 (i.p.) + 200 mg kg–1 WBP (i.g.) |
Composition and physicochemical characteristic of WBP.
| Sample | WBP |
|---|---|
| Yield (%)a | 9.32 ± 1.03 |
| Carbohydrate (%)b | 39.67 ± 4.58 |
| Protein (%)b | 4.56 ± 0.75 |
| Uronic acid (%)b | 4.21 ± 0.36 |
| Sulfate group content (%)b | 3.26 ± 0.43 |
| Monosaccharide mole ratio | |
| Ara/Xyl/Gluc | 1:1.07:0.13 |
a The yield was determined by comparing with raw material.
b Values were expressed on the dry basis.
c Sugar components were analyzed by GC.
Figure 1.The FT-IR spectrum of WBP isolated from wheat bran.
Figure 2.The effects of WBP on cytokines secretion in RAW 264.7 cells. (a) RAW 264.7 cells were treated with WBP at the various concentrations for 24 h and the cell viability was determined using an MTT assay. (b–d) The RAW 264.7 cells were cultured with 12.5, 25, 50 or 100 μg ml–1 of WBP for 24 h. In order to rule out possible endotoxin contamination, WBP or LPS were pretreated with polymyxin B (100 μg ml–1) for 30 min before challenging RAW 264.7 cells. The level of NO was detected by Griess reagent; PGE2 and TNF-α were measured by ELISA kits. Each value is the mean ± standard deviation (n = 3). Any significant differences between polymyxin B-treated and -untreated groups were analyzed using the Student’s t-test (*p < 0.05).
Figure 3.The effect of WBP on the expression of mRNAs of iNOS, COX-2, and TNF-α in RAW 264.7 cells. RAW 264.7 cells (5 × 106 cells ml–1) were incubated with 100 μg ml–1 WBP for the indicated periods of time. Total RNA was isolated and the expression of iNOS, COX-2, and TNF-α was determined by semi-quantitative PCR as described in the text. A representative gel graph from three independent experiments was shown.
Figure 4.Effect of WBP on the nuclear translocation of NF-κB and AP-1. RAW 264.7 cells were transiently co-transfected with NF-κB-luc (a) or AP-1-luc (b). Forty-eight hours after transfection, cells were treated with the indicated concentrations of WBP (12.5–100 μg ml–1) for 1 h. Luciferase activities were determined by luminometry. Any significant differences between WBP-treated and control groups were analyzed using the Student’s t-test (*p < 0.05). (c) RAW264.7 cells (5 × 106 cells ml–1) were incubated with 100 μg ml–1 WBP for the indicated periods of time. The nuclear fractions were collected and protein levels of c-Jun, c-fos, p65, and β-actin were determined by immunoblotting analysis as described in Materials and methods. A representative gel graph from three independent experiments was shown.
Figure 5.Effect of WBP on the activation of the upstream signaling pathways. RAW264.7 cells (5 × 106 cells ml–1) were incubated with 100 μg ml–1 WBP for the indicated periods of time. (a) The whole-cell lysates were extracted for immunoblotting to determine the levels of phospho- or total MAPKs (ERK, p38, and JNK) identified based on their antibodies. (b) Inhibitory effects of specific inhibitors p38 MAPK kinase (SB203580) on iNOS, COX-2, and TNF-α expression in RAW 264.7 cells. Cells were pre-treated with SB203580 followed by stimulation with 100 μg ml–1 WBP for 6 h. Total RNA was isolated and real time-PCR was performed to determine the mRNA level of each gene with gene-specific primer. Within a column, any significant differences between p38 inhibitor-treated and -untreated groups were analyzed using the Student’s t-test (*p < 0.05). (c) RAW 264.7 cells (5 × 106 cells ml–1) were incubated with 100 μg ml–1 WBP for the indicated periods of time. The whole-cell lysates were extracted for immunoblotting to determine the level of TLR4. (d) Inhibitory effects of anti-TLR4 on WBP-induced NO production in RAW 264.7 cells. Cells were treated with anti-TLR4 or control IgG fraction (10 μg ml–1) for 30 min followed by stimulation with different concentration of WBP (25, 50, or 100 μg ml–1) for 24 h. The level of NO was detected by Griess reagent. Any significant differences between treatments with anti-TLR4 and control antibody were analyzed using the Student’s t-test (*p < 0.05).
Figure 5.(continued)
Effect of WBP on immune organ indices in the CTX-treated mice.
| Groups | Thymus index | Spleen index | |
|---|---|---|---|
| Normal control | 3.77 ± 0.24* | 2.98 ± 0.23* | |
| CTX | 2.64 ± 0.20 | 2.06 ± 0.12 | |
| CTX+WBP (50 mg kg–1) | 2.82 ± 0.25 | 2.32 ± 0.10* | |
| CTX+WBP (100 mg kg–1) | 3.02 ± 0.13* | 2.67 ± 0.21* | |
| CTX+WBP (200 mg kg–1) | 3.12 ± 0.18* | 2.63 ± 0.13* |
Each value is presented as mean ± SD (n = 10).
*p < 0.05 compared to CTX group.
Effect of WBP on cytokines secretion in in the CTX-treated mice.
| Groups | IL-2 (pg ml–1) | IFN-γ (pg ml–1) | |
|---|---|---|---|
| Normal control | 15.72 ± 3.23* | 21.35 ± 4.54* | |
| CTX | 8.57 ± 1.45 | 14.54 ± 1.54 | |
| CTX+WBP (50 mg kg–1) | 9.34 ± 2.36 | 15.45 ± 2.32 | |
| CTX+ WBP (100 mg kg–1) | 11.43 ± 1.03* | 17.24 ± 1.34* | |
| CTX+ WBP (200 mg kg–1) | 11.67 ± 0.98* | 18.61 ± 1.21* |
Each value is presented as mean ± SD (n = 10).
*p < 0.05 compared to CTX group.